CAMBRIDGE, Mass., Dec. 30 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. will hold a live webcast of a conference call at 8:30 a.m. EST on Friday, January 6, 2006 in advance of the 24th Annual JPMorgan Healthcare Conference. Dr. Deborah Dunsire, president and chief executive officer of Millennium, will host the call. She will discuss the Company's key accomplishments in 2005 and goals and financial guidance for 2006.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
The live webcast can be accessed by visiting the Investors section of the Company's website, http://www.millennium.com. Following the webcast, an archived version of the call will be available at the same address for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, its understanding of disease mechanisms, and its industrialized drug discovery platform, Millennium is seeking to develop breakthrough products.
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comMillennium Pharmaceuticals, Inc.CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Inc.,+1-617-761-4734
Web site: http://www.millennium.com//
Company News On-Call: http://www.prnewswire.com/comp/114562.html /
